CareMetx Strengthens Leadership Team with Appointment of Brian Flaherty as Chief Commercial Officer
June 3rd, 2025 5:46 PM
By: Newsworthy Staff
CareMetx enhances its leadership team by appointing Brian Flaherty as Chief Commercial Officer, aiming to improve patient access to specialty therapies through innovative commercial strategies and technology.

CareMetx, a technology-enabled services company focused on facilitating patient access to specialty therapies, has announced the appointment of Brian Flaherty as its new Chief Commercial Officer. This strategic move underscores the company's commitment to addressing the complex challenges of patient access in the healthcare industry. Flaherty's extensive experience in healthcare, life sciences, and data-driven innovation positions him as a key player in driving CareMetx's commercial strategy forward.
With over two decades of leadership in the healthcare sector, Flaherty's most recent role was as Vice President of Real-World Data and Evidence at Cardinal Health’s Specialty Networks Solutions division. His expertise in developing data platforms that enhance patient outcomes across various therapeutic areas will be invaluable to CareMetx. The company aims to leverage his skills to expand patient support capabilities and streamline therapy access, benefiting pharmaceutical manufacturers, providers, and patients alike.
The appointment comes at a pivotal moment for CareMetx and the healthcare industry at large. As access programs become increasingly complex, the demand for partners capable of integrating advanced technology with personalized service is growing. Flaherty's vision for a unified, flexible infrastructure for patient support aligns with CareMetx's mission to reduce delays and simplify workflows for providers, ultimately ensuring a faster and more connected experience for patients.
Jim Rowe, CEO of CareMetx, highlighted the significance of Flaherty's appointment, noting the critical need for leadership that can navigate the evolving landscape of patient access programs. Flaherty's role will be instrumental in advancing the company's commercial efforts, reinforcing its position as a leader in patient access and technology.
This leadership transition also sees Shabbir Ahmed moving to the role of Chief Growth Officer, where he will focus on fostering strategic partnerships and expanding CareMetx's partner ecosystem. Together, these changes reflect the company's dedication to innovation and excellence in improving patient access to specialty therapies. By integrating seamlessly into provider workflows and reducing administrative burdens, CareMetx continues to champion a more coordinated and supportive healthcare experience for all stakeholders involved.
Source Statement
This news article relied primarily on a press release disributed by citybiz. You can read the source press release here,
